Advances in cancer treatment have significantly improved survival, yet many therapies carry potential short- and long-term cardiovascular risks. As survivorship grows, so does the need for clinicians to recognize and manage heart disease in patients with a history of cancer.

In this session, Dr. Susan Dent will review the principles of cardio-oncology, including treatment-related cardiotoxicity, risk assessment strategies, and long-term cardiovascular monitoring in cancer survivors. Emphasis will be placed on multidisciplinary collaboration, prevention strategies, and practical approaches to protecting heart health while optimizing cancer outcomes.

Susan Dent, MD, FRCPC, is a medical oncologist and internationally recognized leader in breast cancer and cardio-oncology. She serves in academic leadership roles in Canada and has dedicated her career to improving outcomes for women with breast cancer, particularly in the areas of treatment-related cardiovascular risk and survivorship care. Dr. Dent is widely published, actively involved in clinical research, and committed to advancing multidisciplinary, evidence-based approaches that optimize both cancer outcomes and long-term health.